Sponsored Links
| Ampio Pharmaceuticals, Inc. Announces Initiation Of Phase 1B Clinical Trial For Its Anti-inflammatory Drug Ampion™ |
 |
 |
 |
| Medical News - Arthritis and Rheumatology | |||
|
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE)("Ampio") announced that it received ethics board approval for a Phase 1B clinical trial in Australia of its biologic anti-inflammatory agent, Ampion™... Read more: Arthritis / Rheumatology News From Medical News Today
|